EVO Shares Embark Early Education Limited
ASX · ASXLast in our picks 2026-10-17 — not in the current list; analysis below is from that screen
Specialty pharmaceutical portfolio provides potential growth from prescription expansion and pipeline execution.
Signal breakdown
- ▸Product sales growth and pipeline updates could improve sentiment.
- ▾Below 50-day MA (-5.33%)
- ▸Volume 2.18× average — accumulation
- ▾Near 52-week low (12.1% of range)
Is EVO a buy right now?
Trend: EVO is trading below the 50-day average (-10.98%), RSI 21 — oversold territory, with a 3-month return of -10.98%.
Valuation & quality: Embark Early Education Limited trades on forward P/E 6.5, price-to-book 0.84; fundamentals show net margin -5.9%, return on equity -6.7%, revenue growth -4.4% year on year.
Analyst consensus: 1 analysts have a mean 12-month price target of A$0.63 (+72.6% vs the last close; range A$0.63 – A$0.63), consensus rating “none”.
Income: trailing dividend yield 16.67%.
Our screen: ACCUMULATE (score 1) — Specialty pharmaceutical portfolio provides potential growth from prescription expansion and pipeline execution.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -25.50% | +4.90% | -4.70% | -4.90% | +5.10% | +9.80% | -8.90% | -9.80% |
Fundamentals
Analyst price target
Technical signals
About Embark Early Education Limited
Embark Early Education Limited provides early childhood education (ECE) and care services in Australia. It owns and operates ECE centers. Embark Early Education Limited was incorporated in 2014 and is based in Helensvale, Australia.
Sector: Consumer Defensive · Industry: Education & Training Services · Australia · 1,100 employees · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.